Drug Profile
Efavirenz/lamivudine/tenofovir disoproxil fumarate - Aurobindo Pharma
Alternative Names: Efavirenz 600mg/lamivudine 300mg/tenofovir disoproxil fumarate 300mg - Aurobindo Pharma; Efavirenz/tenofovir disoproxil fumarate/lamivudine - Aurobindo Pharma; Lamivudine/efavirenz/tenofovir disoproxil fumarate - Aurobindo Pharma; Lamivudine/tenofovir disoproxil fumarate/efavirenz - Aurobindo Pharma; Tenofovir disoproxil fumarate/efavirenz/lamivudine - Aurobindo PharmaLatest Information Update: 27 Nov 2018
Price :
$50
*
At a glance
- Originator Aurobindo Pharma
- Class Alkynes; Antiretrovirals; Benzoxazines; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Phosphonic acids; Purines; Pyrimidine nucleosides
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections